Trending
- Lutris Pharma to Present Updated Data from Its Phase 2 Trial of LUT014 Gel for the Treatment of Patients With EGFRI-Induced Acneiform Rash at the EADV Congress
- U.S. Polo Assn. Taps David Swetman as Global Design Lead, Men’s and Boys’ as Brand Targets $4 Billion in Global Retail Sales
- Pakistan inflation, Lahore price gaps expose wider strain
- Emirates enters winter season with strong booking momentum
- Nitinotes Announces First EASE™ Clinical Trial Procedures at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Italy
- Nepal estimates $4.78 billion for flood reconstruction
- Cellebrite CTO Chris Wade to Lead Cellebrite Labs, Sharpening Focus on Mobile Research
- Jetour UAE and Elite Group Holding Renew Strategic Partnership with Al Ain Football Club
